Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
3.420
-0.150 (-4.20%)
At close: Aug 1, 2025, 4:00 PM
3.440
+0.020 (0.58%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Kyverna Therapeutics Stock Forecast

KYTX's stock price has decreased by -60.51% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts that cover Kyverna Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $19, which forecasts a 455.56% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $33.

Price Target: $19.00 (+455.56%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$5.00$19$20$33
Change+46.20%+455.56%+484.80%+864.91%
* Price targets were last updated on May 27, 2025.

Analyst Ratings

The average analyst rating for Kyverna Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy111222
Buy333333
Hold111000
Sell000000
Strong Sell000000
Total555555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Upgrades
$4$5
Strong BuyUpgrades$4$5+46.20%May 27, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Maintains
$6$4
HoldMaintains$6$4+16.96%Apr 3, 2025
Morgan Stanley
Morgan Stanley
Buy
Maintains
$40$20
BuyMaintains$40$20+484.80%Apr 1, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Maintains
$7$6
HoldMaintains$7$6+75.44%Nov 20, 2024
Wells Fargo
Wells Fargo
Buy
Maintains
$44$24
BuyMaintains$44$24+601.75%Nov 15, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.73
from -3.33
EPS Next Year
-3.21
from -3.73
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028
Revenue
5.66M7.03M----1.42M24.28M
Revenue Growth
-24.20%-----1,611.99%
EPS
-99.10-63.43-89.61-3.33-3.73-3.21-3.64-3.59
EPS Growth
--------
Forward PE
--------
No. Analysts
----8864
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a4.5M
Avgn/an/a1.4M
Lown/an/an/a

Revenue Growth

Revenue Growth20252026202720282029
High---
Avg---
Low---

EPS Forecast

EPS20252026202720282029
High-3.60-1.69-2.81
Avg-3.73-3.21-3.64
Low-4.14-4.09-4.27

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.